Radiology

Positron Corporation Enters Industry Partnership Agreement with MedAxiom

Buffalo, NY, Oct. 02, 2025 (GLOBE NEWSWIRE) — Positron Corporation (“Positron” or the “Company”) (OTC: POSC), a leading molecular imaging technology company specializing in PET and PET-CT imaging systems and clinical services is pleased to announce a partnership with MedAxiom, the cardiovascular community’s premier source for organizational performance solutions. 

Former Founding Director of the NIH Center for Interventional Oncology & Chief of Interventional Radiology, Dr. Bradford Wood, MD joins DeepSight as Vice President of Strategic Partnerships

SANTA CLARA, Calif., Oct. 1, 2025 /PRNewswire/ — DeepSight Technology, a leader in advanced interventional ultrasound solutions, is proud to announce the appointment of Bradford Wood, MD, formerly of the National Institutes of Health (NIH), as Vice President of Strategic Partnerships. Dr….

Dr. Sean Raj, MD, MBA, Named Chief Medical Officer of SimonMed Imaging, Expanding Role Alongside Chief Innovation Officer

SCOTTSDALE, Ariz., Sept 14, 2025 – SimonMed Imaging (“SimonMed”), one of the nation’s leading outpatient medical imaging providers and radiology practice, is proud to announce the appointment of Dr. Sean Raj, MD, MBA, to Chief Medical Officer, in addition to his ongoing role as Chief Innovation Officer. A nationally recognized […]

Tempus Receives U.S. FDA Special 510(k) Clearance for Updated Tempus Pixel Device

CHICAGO–(BUSINESS WIRE)–Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its updated Tempus Pixel, an AI-powered cardiac imaging platform. This update allows the generation of T1 […]

Realize Medical and Canon USA Partner to Redefine Procedural Planning Through Spatial Computing with VR and Imaging Technology

Collaboration aims to create the lab of the future, enabling safer, faster, and more precise interventions Key Benefits of Partnership  Integration of VR and imaging: Combines Realize Medical’s VR platform with Canon’s imaging solutions for an immersive and streamlined procedural planning experience. Enhanced clinical decision-making support: Enables safer, faster, and more precise interventions through advanced visualization. Future-ready technology: Builds the foundation for the connected, intelligent interventional lab of the future. Clinical focus areas: Initial applications in pediatric cardiology and adult structural heart disease, with broader expansion planned.  OTTAWA, Ontario, Sept. 10, 2025 (GLOBE NEWSWIRE) — Realize Medical and Canon USA, Inc. today announced a strategic partnership to combine Realize Medical’s cutting-edge VR platform with Canon’s advanced imaging solutions, setting a new standard for procedural planning in interventional medicine. This collaboration combines the power of spatial computing with world-class medical imaging to accelerate safer, faster, and more precise interventions — a critical step toward creating the lab of the future.  “Canon shares our vision for a more connected, intelligent procedural suite,” said Justin Sutherland, Ph.D., Chief Executive Officer of Realize Medical. “This partnership not only enables broader access to Elucis but also accelerates our joint mission to transform clinical decision-making through spatial computing.”  The initial focus of this collaboration will be in pediatric cardiology and adult structural heart disease, with plans to expand into additional interventional specialties in the future.  “The lab of the future will give physicians the ability to plan interventions in a fully immersive mixed reality environment – improving clarity, confidence, and care,” said Jaimin Chung, Managing Director, IXR/VL BU, Canon USA. “Guided by our Made for Life philosophy, Canon Medical’s collaboration with Realize Medical brings this innovation to pediatric intervention today with new applications for adult care already on the horizon.” Realize Medical and Canon USA will showcase their integrated technologies at the Transcatheter Cardiovascular Therapeutics Annual Meeting from October 25–28, 2025, in San Francisco, CA. Representatives are invited to visit Realize Medical in the Canon Medical Booth #1657 for hands-on demonstrations with Elucis.   Media Contact at Realize Medical  Melissa Kois Marketing Lead melissa@realizemed.com | 647-962-9057 www.realizemed.com   Media Contact at Canon USA  Oliva DuarteDirector, Corporate Communicationsoduarte@us.medical.canon | 831-877-0590https://us.medical.canon/

Two New Publications from the Independent THERMAC Trial Featuring IceCure’s ProSense® in Breast Cancer Finds 95% of Patients Satisfied with Thermal Ablation; ProSense® Cryoablation Achieves Highest Complete Ablation Rate

Article published in European Journal of Surgical Oncology focused on cosmetic outcomes and patient satisfaction reports 95% of patients were very satisfied or satisfied with thermal ablation Article published in Radiology demonstrated that cryoablation with ProSense® achieved the highest…